The vaccine book
Author(s)
Bibliographic Information
The vaccine book
Academic Press, an imprint of Elsevier, c2016
2nd ed
- : [pbk.]
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
The Vaccine Book, Second Edition provides comprehensive information on the current and future state of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use.
Although vaccines are now available for many diseases, there are still challenges ahead for major diseases, such as AIDS, tuberculosis, and malaria. This book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines. It answers common questions regarding the use of vaccines in the context of a rapidly expanding anti-vaccine environment.
This new edition is completely updated and revised with new and unique topics, including new vaccines, problems of declining immunization rates, trust in vaccines, the vaccine hesitancy, and the social value of vaccines for the community vs. the individual child's risk.
Table of Contents
Part I: Understanding Vaccine Impact at Population and Individual Levels 1. The Impact of Vaccination on the Epidemiology of Infectious Diseases 2. How Vaccines Work
Part II: How to Design, Assess and Produce Vaccines 3. Vaccine Design in the 21st Century 4. Vaccine Adjuvants 5. Vaccine Production: Main Steps and Considerations 6. How are Vaccines Assessed in Clinical Trials? 7. Immunological Correlates of Vaccine-Mediated Protection
Part III: Vaccine Safety 8. How Vaccine Safety is Monitored 9. Vaccination and Autoimmune Diseases
Part IV: New Vaccination Strategies 10. Maternal Immunization: Protecting Vulnerable Populations 11. New Challenges for Pertussis Vaccines
Part V: Recently Introduced Vaccines 12. Pneumococcus, Pneumococcal Disease, and Prevention 13. Human Papillomavirus Vaccines 14. Rotavirus Vaccines
Part VI: New Approaches for Needed Vaccines 15. Antiviral Vaccines: Challenges and Advances 16. New Approaches for Needed Vaccines: Bacteria 17. Vaccines Against Parasites
Part VII: Major Global Vaccine Challenges 18. Tuberculosis Vaccines 19. Major Global Vaccine Challenges: Recent Progress in Malaria Vaccine Development 20. AIDS Vaccines 21. Influenza Vaccines and Vaccination Strategies
Part VIII: Ethical Considerations 22. Ethical Considerations in Vaccine Trials in Resource-Limited Settings
Part IX: Vaccine Economics 23. Economic Considerations for the Development of Global Vaccines: a Perspective From the Vaccine Industry 24. Introduction of Vaccines Into National Programs 25. Transitioning Immunization Into the Health Care System: Strengthening Routine Immunization in India
Part X: Trust in Vaccines 26. Vaccine Acceptance 27. Trust and Confidence in Vaccines: Tales of Three Vaccines, Lessons for Others
Part XI: Future Challenges 28. Vaccines for Emerging Viral Diseases 29. Cancer Immunotherapy by Checkpoint Blockade 30. Adoptive Cellular Therapy With Synthetic T Cells as an "Instant Vaccine" for Cancer and Immunity
by "Nielsen BookData"